Changes in expression, such as overexpression (e.g., PIWIL1) or downregulation (e.g., PIWIL2), has been identified in several cancers and are associated with poor prognosis (Navarro et al., 2015; Zhang et al., 2023). Here, PIWIL1 is linked to cancer.